Bioinformatics analysis revealed that the effects of AS3MT on epilepsy likely involved multiple targets including MTHFR, GSTM1, CYP17A1, NT5C2, YBX3, CNNM2, CACNB2, and TRIM26. This evidence concerns the gene AS3MT and epilepsy.